Surveys. by Thierry Jean (20691795)

Subjects:

Descriptive statistics of outcomes at baseline, post-intervention, and follow-up and estimates of the linear mixed effects model for the outcomes. by Ana Beato (20489933)

Subjects:

Association between CAP value and carotid-femoral pulse wave velocity. by Johannes Nairz (18010746)

Subjects:

Characteristics of the study population. by Johannes Nairz (18010746)

Subjects:

Boxplot mean cfPWV comparisons. by Johannes Nairz (18010746)

Subjects:

Study flow chart. by Johannes Nairz (18010746)

Subjects:

Oviduct Glycoprotein 1 (OVGP1) Diagnoses Polycystic Ovary Syndrome (PCOS) Based on Machine Learning Algorithms by Fengjuan Wang (768949)

Subjects:

Flowchart of included and excluded patients. by P.G.J. ter Horst (21743830)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 3 level. by P.G.J. ter Horst (21743830)

Subjects:

S1 Data - Medication, age and abstinence days associated with low semen quality: A cross-sectional study in more than 7000 men visiting the centre for reproductive medicine by P.G.J. ter Horst (21743830)

Subjects:

Univariable and multivariable analyses (age-adjusted), concerning a selection of medicaments p < 0.1 and n ≥ 10. by P.G.J. ter Horst (21743830)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 7 level. by P.G.J. ter Horst (21743830)

Subjects:

Characteristics of the study group. by P.G.J. ter Horst (21743830)

Subjects:

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning medicament(s) use and Low Semen Quality (LSQ). by P.G.J. ter Horst (21743830)

Subjects:

A. Proportion of men with Low Semen Quality (LSQ) including 95% confidence interval (CI) versus prevalence, overall and for men on medication(s) (M); B: Point estimates with 95% CI... by P.G.J. ter Horst (21743830)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 5 level. by P.G.J. ter Horst (21743830)

Subjects:

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning a selection of medicaments with n ≥ 10 medicament users and p < 0.1 by univariate analysis.... by P.G.J. ter Horst (21743830)

Subjects:

This dataset includes detailed information for 22,016 individuals. by Yeo Ju Sohn (18536198)

Subjects:

Clinical and epidemiological characteristics. by Domingos L. S. Rios (20496173)

“…In men, BMI and fat mass decreased by 12.9% and 25.3 at 3 months and 23.6% and 45.3% at 6 months, respectively. …”

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …”